Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Bhuyan, Zaied Ahmed ^a   Asanoma, Michihito ^a   Iwata, Akiko ^a   Ishifune, Chieko ^a   Maekawa, Yoichi ^a   Shimada, Mitsuo ^a   Yasutomo, Koji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE; NOTCH RECEPTOR; PROTEIN RBPJ; RECOMBINANT CYTOKINE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH17 CELL; UVEORETINITIS;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; EYE PROTEINS; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RETINITIS; RETINOL-BINDING PROTEINS; TH17 CELLS; UVEITIS;

EID: 84897565031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089266     Document Type: Article

References (32)

1. Caspi RR (2003) Regulation, counter-regulation, and immunotherapy of autoimmune responses to immunologically privileged retinal antigens. Immunologic research 27: 149-160.
2. Sonoda KH, Sasa Y, Qiao H, Tsutsumi C, Hisatomi T, et al. (2003) Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis. J Immunol 171: 2652-2659. (Pubitemid 37025579)
3. Kitamura M, Iwabuchi K, Kitaichi N, Kon S, Kitamei H, et al. (2007) Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol 178: 6567-6572. (Pubitemid 46717440)
4. Caspi R (2008) Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunologic research 42: 41-50.
5. Shao H, Liao T, Ke Y, Shi H, Kaplan HJ, et al. (2006) Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Experimental eye research 82: 323-331. (Pubitemid 43122119)
6. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, et al. (1999) Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. The Journal of experimental medicine 189: 219-230. (Pubitemid 29063244)
7. Caspi RR, Silver PB, Chan CC, Sun B, Agarwal RK, et al. (1996) Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. Journal of immunology 157: 2668-2675. (Pubitemid 126450484)
8. Luger D, Silver PB, Tang J, Cua D, Chen Z, et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. The Journal of experimental medicine 205: 799-810. (Pubitemid 351549879)
9. Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, et al. (2008) Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. International immunology 20: 209-214. (Pubitemid 351234388)
10. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767. (Pubitemid 37328814)
11. Maekawa Y, Tsukumo S, Chiba S, Hirai H, Hayashi Y, et al. (2003) Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 19: 549-559. (Pubitemid 37311436)
12. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, et al. (2004) Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 20: 611-622. (Pubitemid 38638130)
13. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, et al. (2004) Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515-526. (Pubitemid 38610236)
14. Tanaka S, Tsukada J, Suzuki W, Hayashi K, Tanigaki K, et al. (2006) The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells. Immunity 24: 689-701. (Pubitemid 43884897)
15. Bailis W, Yashiro-Ohtani Y, Fang TC, Hatton RD, Weaver CT, et al. (2013) Notch simultaneously orchestrates multiple helper T cell programs independently of cytokine signals. Immunity 39: 148-159.
16. Minter LM, Turley DM, Das P, Shin HM, Joshi I, et al. (2005) Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature immunology 6: 680-688. (Pubitemid 41716741)
17. Reynolds ND, Lukacs NW, Long N, Karpus WJ (2011) Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis. Journal of immunology 187: 2803-2813.
18. Bassil R, Zhu B, Lahoud Y, Riella LV, Yagita H, et al. (2011) Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. Journal of immunology 187: 2322-2328.
19. Ishida W, Fukuda K, Sakamoto S, Koyama N, Koyanagi A, et al. (2011) Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody. Investigative ophthalmology & visual science 52: 8224-8230.
20. Maekawa Y, Minato Y, Ishifune C, Kurihara T, Kitamura A, et al. (2008) Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nature immunology 9: 1140-1147.
21. Radtke F, Wilson A, Mancini SJ, MacDonald HR (2004) Notch regulation of lymphocyte development and function. Nature immunology 5: 247-253. (Pubitemid 38332121)
22. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718. (Pubitemid 46889754)
23. Alam MS, Maekawa Y, Kitamura A, Tanigaki K, Yoshimoto T, et al. (2010) Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 107: 5943-5948.
24. Calder VL, Zhao ZS, Wang Y, Barton K, Lightman SL (1993) Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis. Immunology 79: 255-262. (Pubitemid 23172221)
25. Kolls JK, McCray PB Jr, Chan YR (2008) Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol 8: 829-835.
26. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, et al. (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659. (Pubitemid 47615503)
27. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. The Journal of clinical investigation 118: 597-607. (Pubitemid 351206549)
28. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. The Journal of clinical investigation 119: 3573-3585.
29. Ke Y, Sun D, Jiang G, Kaplan HJ, Shao H (2011) IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. Journal of immunology 187: 2130-2139.
30. Boggs K, Henderson B, Reisman D (2009) RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene. Cell Biol Int 33: 318-324.
31. Jin S, Mutvei AP, Chivukula IV, Andersson ER, Ramskold D, et al. (2013) Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKalpha/IKKbeta. Oncogene 32: 4892-4902.
32. Andersen P, Uosaki H, Shenje LT, Kwon C (2012) Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol 22: 257-265.